CVS:NYE-CVS Health Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 55.54

Change

-1.53 (-2.68)%

Market Cap

USD 78.05B

Volume

0.01B

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-08 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

+9.44 (+1.53%)

USD 566.72B
ELV Elevance Health Inc

+2.77 (+0.66%)

USD 95.26B
CNC Centene Corp

+0.60 (+1.00%)

USD 30.37B
MOH Molina Healthcare Inc

-1.06 (-0.32%)

USD 18.86B
OSCR Oscar Health Inc

+0.26 (+1.92%)

USD 4.12B
NEUE NeueHealth Inc

-0.04 (-0.79%)

USD 0.05B
CI Cigna Corp

+23.29 (+7.28%)

N/A
HUM Humana Inc

-5.68 (-1.97%)

N/A

ETFs Containing CVS

XYLU:LSE Global X S&P 500® Covere.. 4.39 % 0.00 %

N/A

USD 0.03B
FXG First Trust Consumer Stap.. 3.80 % 0.64 %

+0.25 (+0.88%)

USD 0.39B
UINC:LSE First Trust US Equity Inc.. 2.76 % 0.00 %

+53.50 (+0.88%)

USD 0.31B
UNCU:LSE First Trust US Equity Inc.. 2.69 % 0.00 %

+0.48 (+0.88%)

USD 0.04B
UVAL:LSE SPDR® MSCI USA Value UCI.. 2.54 % 0.00 %

+0.51 (+0.88%)

USD 0.14B
USVL:LSE SPDR® MSCI USA Value UCI.. 2.54 % 0.00 %

+0.51 (+0.88%)

USD 0.14B
ZPRU:F SSgA SPDR ETFs Europe II .. 2.54 % 0.00 %

N/A

USD 0.13B
ZPRU:XETRA SPDR® MSCI USA Value UCI.. 2.54 % 0.00 %

+0.86 (+0.88%)

USD 0.13B
UVAL:SW SPDR® MSCI USA Value UCI.. 2.54 % 0.00 %

+0.82 (+0.88%)

USD 0.14B
XHS SPDR® S&P Health Care Se.. 2.12 % 0.35 %

+2.06 (+0.88%)

USD 0.08B
VMAX REX VolMAXX Long VIX Futu.. 2.11 % 0.00 %

+0.45 (+0.88%)

USD 0.01B
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

+0.03 (+0.88%)

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

+0.12 (+0.88%)

USD 0.09B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

+0.02 (+0.88%)

N/A
SYBN:F SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

+0.18 (+0.88%)

USD 0.10B
SYBN:XETRA SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

+0.21 (+0.88%)

USD 0.10B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.30 % 0.00 %

+0.41 (+0.88%)

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.30 % 0.00 %

+0.16 (+0.88%)

USD 0.23B
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

+0.02 (+0.88%)

USD 0.37B
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

-0.08 (0.88%)

USD 0.93B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

+0.01 (+0.88%)

N/A
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

-0.01 (0.88%)

USD 0.07B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.97 (+0.88%)

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

-0.13 (0.88%)

USD 0.60B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

-0.21 (0.88%)

N/A
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

-0.05 (0.88%)

USD 0.98B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

-0.04 (0.88%)

USD 0.09B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

+0.02 (+0.88%)

CAD 0.09B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

-0.10 (0.88%)

USD 2.74B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

-0.02 (0.88%)

USD 2.30B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

+0.34 (+0.88%)

CAD 0.05B
RTH VanEck Retail ETF 0.00 % 0.35 %

+0.57 (+0.88%)

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

+0.68 (+0.88%)

N/A
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

-0.03 (0.88%)

USD 2.12B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

+0.58 (+0.88%)

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.63 (+0.88%)

N/A
STPL:CA BMO Global Consumer Stapl.. 0.00 % 0.40 %

+0.05 (+0.88%)

CAD 0.04B
ICAN 0.00 % 0.50 %

N/A

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

+3.25 (+0.88%)

USD 0.09B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A
LBAY Tidal ETF Trust - Leather.. 0.00 % 0.00 %

-0.08 (0.88%)

USD 0.04B
NVQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -64.83% 38% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -64.83% 38% F 7% C-
Trailing 12 Months  
Capital Gain -58.97% 50% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -58.97% 50% F 7% C-
Trailing 5 Years  
Capital Gain -61.68% 50% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -61.68% 50% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain 2.08% 25% F 42% F
Dividend Return 4.56% 50% F 43% F
Total Return 2.48% 100% F 56% F
Risk Return Profile  
Volatility (Standard Deviation) 28.57% 25% F 38% F
Risk Adjusted Return 15.97% 38% F 33% F
Market Capitalization 78.05B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 15.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector